Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.

Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO Oncol Pract. 2024 Jan; 20(1):59-68.

View in: PubMed

subject areas

Aged
Bone Neoplasms
Child
Delivery of Health Care
Humans
Male
Prostatic Neoplasms, Castration-Resistant
Retrospective Studies

authors with profiles

Ted Skolarus